openPR Logo
Press release

Aptamers Market Insights on Size, Trends Analysis, Driving Factors and Growth Opportunities until the End of 2022 | Aptamers Market Classification – By Product Type (DNA, RNA, XNA, Peptides), By Application (Diagnostics, Therapeutics, Research and Devel

07-24-2018 11:35 AM CET | Health & Medicine

Press release from: Fact.MR

FactMR

FactMR

Dublin, Ireland, 2018-Jul-24 — The global aptamers market shows significant growth rate during the period of forecast owing to many factors such as high investments in biopharmaceutical and pharmaceutical companies, technological advancements and increased research and development. The added benefits of aptamers such as their fast generation as compared to antibiotics which helps in rapid treatment of diseases and drug discoveries also supports the growth of the global aptamer market. This FactMR report analyzes the expansion of global Aptamers Market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

The scope of FactMR’s report is to analyze the global Aptamers Market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global aptamers market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to aptamers.

Download Free Sample Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=173

Aptamers can be generated quickly as compared to antibodies which is a plus point and hence they are used widely in treating diseases. The global aptamers market is expected to witness a probable increase in demand and hence growth which is influenced by factors associated with the aptamer product. The increase in the research and development activities along with increase in the investments in the biotechnological and pharmaceutical companies has driven the use of aptamers and hence the global aptamer market. Other advantages such as technological advancements followed by patent expiration of SELEX (Systematic Evolution of Ligands by Exponential enrichment technology), is likely to boost the growth of the aptamers market on a global scale.

The development in aptamers technology has brought more effective, efficient and cost-reduced process for binding larger molecules as compared to antibodies. This is another aspect contributing to the growth of the global aptamers market. Also, the increasing use of aptamers in disease treatment and drug discovery have a significant impact ensuring its growth in a positive direction.

Aptamers are peptide molecules or oligonucleotides which bind to a target lipid, nucleic acid molecules or proteins. They are rapidly generated and applied in the specific detection, inhibition and characterization of proteins. They are used as detecting reagents, can be used as functional proteomic levels with antibodies, can be used as small molecules as well as pharmaceutical leads. They also can be engineered to attain higher affinity to a large number of target groups. Aptamers can be generated much faster than antibodies and hence can be used to cure diseases much faster than antibodies.

The peptide segment by product type has high potential as it grows at a super exponential rate and is anticipated to reflect a CAGR of 30.1% during the period of forecast of 2017 to 2022 and a high gain in the BPS by the end of 2022. The DNA segment shows high market share by value as of 2017, thereby establishing dominance over other segments. However, the current rate of peptide segment can take it up a notch to actually match the market share of DNA segment. The XNA and RNA segments have more or less similar growth rates during the forecast period. DNA, RNA and XNA, however, bound to experience loss in the BPS by the end of 2022.

Check Complete Report Here - https://www.factmr.com/report/173/aptamers-market

The North America region is supposed to be highly lucrative region for the aptamers market and shows a high market attractiveness index. With respect to revenue in 2017, the North America region is expected to dominate the global market and this trend is poised to continue over the forecast period. The region is expected to grow at a high growth rate to reflect a CAGR of 26.3% during the period of forecast. North America region is the largest market for all types of segments of the aptamers market. Following North America, Europe region also shows good growth potential in the aptamers market. The main reason for North America to prosper in this market is the technological advancement and the level of development that has taken place. The research and development centers also receive high investment support which make the most of them.

Pharmaceutical Companies and CRO Segments to Register Equal growth; Academic and Research Centers to show high pace

The academic and research centers by end user type are growing at a very high rate and poised to show a CAGR of 26.4% during the period of forecast. The pharmaceutical companies and the contract research organization (CRO) segments are expected to grow alongside one another, and are expected to show similar growth rates throughout the period of forecast. The bio-pharmaceutical companies segment shows the highest market share by revenue in 2017, and thereby dominates the global market and also reflects to gain a comparatively high BPS by the end of 2022.

Aptamers Market: Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of the global aptamers market through 2022, which include AM Biotech, Aptagen, LLC, Aptamer Sciences, Inc., Aptamer Group, Aptus Biotech, Base Pair Biotechnologies, Inc., NeoVentures Biotechnology Inc., Somalogic, Inc., TriLink BioTechnologies, LLC and Vivonics Inc.

Table of Contents -

Global Aptamers Market - Executive Summary
Global Aptamers Market Overview
2.1. Introduction

       2.1.1. Global Aptamers Market Taxonomy

       2.1.2. Global Aptamers Market Definition

2.2. Global Aptamers Market Size (US$ Mn) and Forecast, 2012-2022

       2.2.1. Global Aptamers Market Y-o-Y Growth

2.3. Global Aptamers Market Dynamics

2.4. Regulations

2.5. Supply Chain

2.6. Cost Structure

2.7. Average Pricing Analysis

2.8. List of Distributors

2.9. Key Participants Market Presence (Intensity Map) By Region

Continued……………………..

Order a copy of Global Market Research Report Here - https://www.factmr.com/checkout/173/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Sports market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us -

FactMR
Suite 9884
27 Upper Pembroke Street, Dublin 2, Ireland
Telephone @ +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aptamers Market Insights on Size, Trends Analysis, Driving Factors and Growth Opportunities until the End of 2022 | Aptamers Market Classification – By Product Type (DNA, RNA, XNA, Peptides), By Application (Diagnostics, Therapeutics, Research and Devel here

News-ID: 1142282 • Views: 137

More Releases from Fact.MR

05-25-2022 | Health & Medicine
fact.mr
Pulmonary Arterial Hypertension (PAH) Market Was Projected To Accelerate At A CA …
Pulmonary Arterial Hypertension (PAH) Market Analysis by Drug Class (Prostacyclin & Prostacyclin Analogs, Endothelin Receptor Antagonists, Phosphodiesterase-5 (PDE-5) Inhibitors), by Pipeline Analysis (Early-stage, Late-stage), by Region - Global Forecast 2021-2028 The pulmonary arterial hypertension (PAH) market was valued at US$ 5.2 Bn in 2020 and is projected to accelerate at a CAGR of 5.4% to reach US$ 13.5 Bn by 2028. Click here to get a sample report (with full table of
05-25-2022 | Health & Medicine
fact.mr
Preventive Healthcare Technologies And Services Is Project To Surge Ahead At An …
Preventive Healthcare Technologies and Services Market Analysis by Early Detection & Screening Technologies, by Prophylaxis Technologies, by Advanced Technologies to Reduce Errors, by Chronic Disease Management Technologies, by Region - Global Forecast 2021-2028 The preventive healthcare technologies and services market is projected to surge ahead at an astronomical CAGR of 13% from 2021 to 2028. In 2020, revenue from preventive healthcare technologies and services was US$ 217.1 Mn, which is anticipated
Worldwide Demand For Digital Experience Platform Has Predicted To Grow At An Imp …
Digital Experience Platform Market Analysis By Component (Platform & Services) By Deployment Type (On Premises & Cloud based Digital Experience Platform) By Vertical & By Region - Global Market Insights 2022-2032 The digital experience platform market is predicted to grow at an impressive CAGR of 10.2%. It is expected to reach nearly US$ 29.5 Bn by 2032, going up from US$ 9.9 Bn in 2021. "Due to the growing demand of Business
05-25-2022 | Health & Medicine
fact.mr
Sales Of Bone Grafts And Substitutes Are Slated To Rise At A CAGR Of 4.9% To Rea …
Bone Grafts and Substitutes Market Analysis by Product (Allografts, Synthetic Bone Grafts), by Material (Ceramic-based, Polymer-based, Growth Factor-based, Cell-based), by End User, by Region - Global Forecast 2021-2028 The global bone grafts and substitutes market reached a valuation of US$ 3.06 Bn in 2020. Sales of bone grafts and substitutes are slated to rise at a CAGR of 4.9% to reach US$ 4.44 Bn by the end of 2028. Click here to

All 5 Releases


More Releases for Aptamer

Global Aptamer Technologies Market Forecast Up to 2031
Visiongain has launched a new report Aptamer Technologies Market Report 2021-2031: Forecasts by Function (Affinity Reagents, Molecular Probes, Cytomics Analysis), by Type (DNA-Based Aptamers, RNA-Based Aptamers, XNA-Based Aptamers), by Technology (SELEX Technology, Modified Oligonucleotides, Oligonucleotide Sythesis, Next-Generation Sequencing, Nanoparticles & Quantum Dot Labels, Surface Plasmon Resonance and Biolayer Interfermotrym, Bioinformatics), by Application (Diagnostics, Therapeutics Development, Research & Development), by End-user (Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, Contract
04-02-2021 | Health & Medicine
Fact.MR
SELEX Aptamer Selection Process to be the Gold Standard Selection Technique in A …
Though currently limited to the pharmaceutical industry, intense research & development initiatives taken by players in the aptamer market are projected to broaden the existing scope of application of these neoteric molecules to create horizontal market opportunities. With enhanced properties, aptamers are likely to play a pivotal role in environmental monitoring and quality control applications in the agriculture industry. Click here to Get Synopsis of the Report https://www.factmr.com/report/173/aptamers-market Currently, a significant volume
Aptamers Market 2020-2026 to Witness Exponential Growth || Key Players - Aptamer …
The market data analysed and evaluated in this Aptamers Market business document makes to achieve the business goals and objectives in preset time frame. Moreover, Global Aptamers business document encompasses all the company profiles of the major players and brands. The report offers a thorough synopsis on the study, analysis and estimation of the market and how it is impacting the industry. To prepare this Aptamers Market report, detailed market
Global Aptamers Market - Industry Trends - Forecast to 2026 || Leading Players - …
Staying informed about the trends and opportunities in the industry is quite a time consuming process where this Aptamers Market report actually helps a lot. The major areas of market analysis such as market definition, market segmentation, competitive analysis and research methodology are studied very carefully and precisely in the whole Aptamers Market report. Various steps are used while generating this report by taking the inputs from a specialized team
What's Driving Aptamers Market Trends? Key Company Profiled In LLC, Aptagen, LLC …
Aptamers are oligonucleotides or peptide molecules that bind to target lipid, protein, or nucleic acid molecules with a high specificity. Aptamers are generated rapidly and applied in the inhibition, specific detection, and characterization of proteins. Aptamers can be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules, and other aptamers. Aptamers can be engineered to have higher affinity and specificity to large number of targets.
Aptamers Market Latest Innovation in 2019 by SOMALOGIC, APTAMER GROUP, APTAMER S …
The global Aptamers market has been estimated to reach USD 401.30 million in 2023. The market is expected to register a CAGR of 17.89% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements. Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16739 Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”. Advancements in the field of aptamer